Bull
$206.70
Scenario price
$236.250
-7.206 (-3.05%)At close
AMETEK, Inc. is a global provider of industrial technology solutions serving a diverse set of niche markets. Its segments include Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The EIG segment designs and manufactures advanced instruments for the process, power and industrial, and aerospace markets. It provides a range of instruments for research and laboratory equipment, ultra-precision manufacturing and metrology, optics, medical, and test and measurement markets. EMG designs and manufactures engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects. It also provides three-dimensional measurement and imaging solutions, including portable measurement arms, laser scanners and trackers, software solutions, and comprehensive service offerings. It is also engaged in instrumentation businesses that design and manufacture solutions for demanding industrial and scientific applications.
AMETEK Inc is a good buy right now, trading at $236.25 with a forward P/E of 31.65, which is attractive compared to its growth prospects. The recent Q2 earnings exceeded expectations with a reported EPS of $2.09, beating estimates by $0.10, and a revenue increase of 14.6% year-over-year. This performance supports a positive outlook, especially with analysts projecting price targets up to $291, suggesting significant upside potential. However, the main risk is the stock being considered overvalued based on a DCF analysis, indicating a potential downside of 29.1% from its intrinsic value estimate of $181.
TD Cowen
$275
2026-08-06
TD Cowen
2026-08-06
Price Target
$275
Seaport Research
$290
2026-08-05
Seaport Research
2026-08-05
Price Target
$290
DA Davidson
$285
2026-08-05
DA Davidson
2026-08-05
Price Target
$285
Mizuho
$285
2026-08-05
Mizuho
2026-08-05
Price Target
$285
RBC Capital
$291
2026-08-05
RBC Capital
2026-08-05
Price Target
$291
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

AMETEK Completes $5 Billion Acquisition of Indicor Instrumentation

AMETEK Completes $5 Billion Acquisition of Indicor Instrumentation

AMETEK Declares $0.34 Quarterly Dividend for Q3 2026

Ametek to Host Q2 2026 Earnings Call on August 4

Ametek Q2 Earnings Exceed Expectations
AMETEK, Inc. is a global provider of industrial technology solutions serving a diverse set of niche markets. Its segments include Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The EIG segment designs and manufactures advanced instruments for the process, power and industrial, and aerospace markets. It provides a range of instruments for research and laboratory equipment, ultra-precision manufacturing and metrology, optics, medical, and test and measurement markets. EMG designs and manufactures engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects. It also provides three-dimensional measurement and imaging solutions, including portable measurement arms, laser scanners and trackers, software solutions, and comprehensive service offerings. It is also engaged in instrumentation businesses that design and manufacture solutions for demanding industrial and scientific applications. It operates in the Industrials sector (INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, A industry).
AMETEK Inc is a good buy right now, trading at $236.25 with a forward P/E of 31.65, which is attractive compared to its growth prospects. The recent Q2 earnings exceeded expectations with a reported EPS of $2.09, beating estimates by $0.10, and a revenue increase of 14.6% year-over-year. This performance supports a positive outlook, especially with analysts projecting price targets up to $291, suggesting significant upside potential. However, the main risk is the stock being considered overvalued based on a DCF analysis, indicating a potential downside of 29.1% from its intrinsic value estimate of $181.
14 analysts cover AME: 13 rate it Buy, 1 Hold and 0 Sell. The average price target is 231.00.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。